Stryker Corporation (NYSE:SYK) Receives Media Impact Score of 0.13
Media stories about Stryker Corporation (NYSE:SYK) have trended somewhat positive on Wednesday, Accern reports. The research firm identifies negative and positive press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Stryker Corporation earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned press coverage about the medical technology company an impact score of 46.3695649095466 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the news stories that may have impacted Accern Sentiment’s analysis:
- Insider Selling: Stryker Corporation (SYK) Insider Sells 1,124 Shares of Stock (americanbankingnews.com)
- Michigan Court Reinstates its Full $254 Million Award to Stryker for Competitor’s Infringing Wound Irrigation Devices (jdsupra.com)
- Stryker Corporation : Earnings Review and Free Research Report: Stryker’s Net Sales Grew 6.1%; Adjusted Earnings Jumped 10.7% (4-traders.com)
- INTEGRA LIFESCIENCES CORPORATION AND STRYKER IS DOMINATING THE MARKET FOR GLOBAL NERVE REPAIR BIOMATERIALS MARKET IN 2016 (medgadget.com)
Shares of Stryker Corporation (SYK) traded down 0.66% during trading on Wednesday, hitting $145.18. The company had a trading volume of 1,080,989 shares. The firm has a 50 day moving average of $143.16 and a 200 day moving average of $134.68. Stryker Corporation has a 12-month low of $106.48 and a 12-month high of $148.84. The stock has a market cap of $54.31 billion, a PE ratio of 32.41 and a beta of 0.80.
Stryker Corporation (NYSE:SYK) last posted its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.51 by $0.02. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The firm had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.98 billion. During the same quarter in the prior year, the business earned $1.39 EPS. The business’s revenue for the quarter was up 6.1% compared to the same quarter last year. On average, analysts forecast that Stryker Corporation will post $6.50 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be issued a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a yield of 1.17%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s dividend payout ratio is 37.95%.
SYK has been the topic of several recent analyst reports. Cowen and Company set a $150.00 target price on Stryker Corporation and gave the company an “outperform” rating in a research note on Wednesday, April 26th. Morgan Stanley reaffirmed an “overweight” rating and set a $160.00 target price (up previously from $155.00) on shares of Stryker Corporation in a research note on Monday, July 10th. Cantor Fitzgerald initiated coverage on Stryker Corporation in a research note on Thursday, June 29th. They set a “neutral” rating and a $153.00 target price on the stock. Zacks Investment Research raised Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 target price on the stock in a research note on Monday, July 17th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $140.00 target price (up previously from $135.00) on shares of Stryker Corporation in a research note on Wednesday, April 26th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and twelve have given a buy rating to the company’s stock. Stryker Corporation presently has an average rating of “Hold” and a consensus price target of $144.03.
TRADEMARK VIOLATION WARNING: “Stryker Corporation (NYSE:SYK) Receives Media Impact Score of 0.13” was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/08/09/stryker-corporation-nysesyk-receives-media-impact-score-of-0-13.html.
In other news, insider David Floyd sold 19,305 shares of the stock in a transaction on Wednesday, July 12th. The stock was sold at an average price of $144.56, for a total value of $2,790,730.80. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Lonny J. Carpenter sold 5,000 shares of the stock in a transaction on Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the transaction, the insider now directly owns 88,207 shares in the company, valued at approximately $12,909,976.52. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 32,810 shares of company stock worth $4,754,958. Company insiders own 7.40% of the company’s stock.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.